Genetic Variation of the BETA-2 Adrenergic Receptor and the Bronchodilatory Response to Albuterol in Patients with Cystic Fibrosis

Genetic Variation of the BETA-2 Adrenergic Receptor and the Bronchodilatory Response to Albuterol in Patients with Cystic Fibrosis

Show other versions (1)

Class of 2012 Abstract === Specific Aims: We sought to determine the influence of genetic variation of ADRB2 on the airway response to albuterol in patients with CF when compared to matched healthy controls at baseline and at 60 minutes following the administration of albuterol (2.5mg diluted in 3m...

Full description

Bibliographic Details
Main Authors:	Herko, Kara, Guthrie, Benjamin, Snyder, Eric
Language:	en_US
Published:	The University of Arizona. 2012
Subjects:	BETA-2 Adrenergic Receptor Bronchodilatory Albuterol Cystic Fibrosis
Online Access:	http://hdl.handle.net/10150/614494 http://arizona.openrepository.com/arizona/handle/10150/614494

Similar Items

Genetic Variation of the BETA-2 Adrenergic Receptor and the Bronchodilatory Response to Albuterol in Patients with Cystic Fibrosis
by: Herko, Kara, et al.
Published: (2012)

Influence of Genetic Variation of the β2 Adrenergic Receptor in Patients with Cystic Fibrosis
by: Skrentny, Thomas, et al.
Published: (2010)

Deposição pulmonar de tobramicina inalatória antes e após fisioterapia respiratória e uso de salbutamol inalatório em pacientes com fibrose cística colonizados por Pseudomonas aeruginosa Pulmonary deposition of inhaled tobramycin prior to and after respiratory therapy and use of inhaled albuterol in cystic fibrosis patients colonized with Pseudomonas aeruginosa
by: Milena Baptistella Grotta, et al.
Published: (2009-01-01)

Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity
by: Ken-Ichiro Tanaka, et al.
Published: (2018-04-01)

Spirometry use in patients prescribed albuterol
by: Ornelas CS, et al.
Published: (2012-01-01)

Genetic Variation of the Beta-2 Adrenergic Receptor and the Phenylethanolamine N-Methyltransferase Enzyme: Influence on Catecholamines, Cardiovascular Regulation, and the Cardiopulmonary Response to Albuterol
by: Martinez, Marina G.
Published: (2014)

Anti-inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases: A review of basic and clinical evidence
by: Zahra Gholamnezhad, et al.
Published: (2015-08-01)

Beta-2 agonists for the treatment of bronchiolitis
by: Constanza Gómez, et al.
Published: (2020-09-01)

Polymorphisms in <it>ADRB2 </it>gene can modulate the response to bronchodilators and the severity of cystic fibrosis
by: Marson Fernando A L, et al.
Published: (2012-09-01)

Regulation of bone formation and resorption by Beta Adrenergic system
by: Fateme Mohammadali, et al.
Published: (2016-04-01)

Severe hypokalemia secondary to abuse of β-adrenergic agonists in a pediatric patient: Case report
by: Carolt Arana Aliaga, et al.

Comparison of Pharmaceutical Quality and Product Performance of Albuterol Inhalers Available in the US and Those Obtained in Mexico for a Fraction of US Cost
by: Nocella, Meira, et al.
Published: (2015)

Cystic Fibrosis - Related Diabetes
by: Marcin Makuch, et al.
Published: (2021-06-01)

Detection of Ampc and Extended-Spectrum Beta-Lactamases in Clinical Isolates of Pseudomonas Aeruginosa from Patients with Cystic Fibrosis
by: Roya Rafiee, et al.
Published: (2016-05-01)

Beta adrenergic blockade in myocardial infarction
by: Yusuf, Salim
Published: (1980)

Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists
by: Chua, K.-P, et al.
Published: (2022)

Lactic acidosis and diastolic hypotension after intermittent albuterol nebulization in a pediatric patient
by: Tehila A. Saadia, et al.
Published: (2015-01-01)

Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics
by: Caimmi Silvia, et al.
Published: (2012-06-01)

The epidemiology of cystic fibrosis related diabetes (CFRD) in cystic fibrosis patients attending the adult cystic fibrosis clinic at the Charlotte Maxeke Johannesburg Academic Hospital
by: Romain, Marc
Published: (2012)

Evaluation of Safety and Efficacy Outcomes from use of Extended Infusion of Beta-Lactam in the treatment of Acute Pulmonary Exacerbations in Cystic Fibrosis
by: Tien, Quang, et al.
Published: (2017)

Frequency of the most common cystic fibrosis mutation in South Carolina
by: Golden, Robert Brian
Published: (2008)

Efeito da obstrução de vias aéreas nas variações das propriedades resistivas e elásticas do sistema respiratório de asmáticos, mediadas pelo uso de salbutamol Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma
by: Juliana Veiga, et al.
Published: (2009-07-01)

Beta adrenergic blockers poisoning
by: Tadić Milorad, et al.
Published: (2016-01-01)

Comparison of beta2-adrenergic and hyperemia-induced arterial vasodilation assessed by digital pulse contour analysis
by: Andrzej Wykretowicz, et al.
Published: (2019-03-01)

A case of cystic fibrosis
by: Maria Alice Monti, et al.
Published: (2009-09-01)

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old
by: C. Prados, et al.
Published: (2017-01-01)

The role of α₂macroglobulin the pathogenesis of cystic fibrosis
by: Bridges, Michael Anthony
Published: (2010)

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
by: Frost F, et al.
Published: (2019-04-01)

Cystic Fibrosis-Related Diabetes
by: Kayani Kayani, et al.
Published: (2018-02-01)

Impact on Vitamin D Status in Cystic Fibrosis Patients After Implementation of 2012 Cystic Fibrosis Foundation Guidelines
by: Bhakta, Dharti, et al.
Published: (2015)

THE EFFECTS OF BETA-ADRENERGIC BLOCKADE ON EXERCISE CAPACITY AND THERMOREGULATION IN TRAINED AND UNTRAINED SUBJECTS.
by: FREUND, BEAU JEFFERE.
Published: (1985)

Sympathetic innervation contributes to perineural invasion of salivary adenoid cystic carcinoma via the β2-adrenergic receptor
by: Ma C, et al.
Published: (2019-02-01)

Cutaneous Manifestations of Cystic Fibrosis
by: Chiriac Anca, et al.
Published: (2018-03-01)

Bronchodilatory and B-adrenergic effects of methanolic and aqueous extracts of Althaea root on isolated tracheobronchial smooth rat muscle
by: Behrang Alani, et al.
Published: (2015-01-01)

Combined computational and experimental studies of molecular interactions of albuterol sulfate with bovine serum albumin for pulmonary drug nanoparticles
by: Lin SH, et al.
Published: (2016-09-01)

Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic
by: Sana Hasan, et al.
Published: (2021-03-01)

Atypical cystic fibrosis diagnosed in a14-year-old boy
by: Iwona Stelmach, et al.
Published: (2016-06-01)

Factors Influencing Lung Function in Patients with Cystic Fibrosis in Western Romania
by: Dediu M, et al.
Published: (2021-06-01)

Cystic fibrosis
by: Radlović Nedeljko
Published: (2012-01-01)

Postural stability in patients with cystic fibrosis
by: Jarosław Prusak, et al.
Published: (2018-09-01)

Cannot write session to /tmp/vufind_sessions/sess_qs1onkc8it9adhodrsqfb2hfns